147 related articles for article (PubMed ID: 16795080)
1. TGF-beta2 stimulates cranial suture closure through activation of the Erk-MAPK pathway.
Lee SW; Choi KY; Cho JY; Jung SH; Song KB; Park EK; Choi JY; Shin HI; Kim SY; Woo KM; Baek JH; Nam SH; Kim YJ; Kim HJ; Ryoo HM
J Cell Biochem; 2006 Jul; 98(4):981-91. PubMed ID: 16795080
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis.
Opperman LA; Adab K; Gakunga PT
Dev Dyn; 2000 Oct; 219(2):237-47. PubMed ID: 11002343
[TBL] [Abstract][Full Text] [Related]
3. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
Greenwald JA; Mehrara BJ; Spector JA; Warren SM; Crisera FE; Fagenholz PJ; Bouletreau PJ; Longaker MT
J Bone Miner Res; 2000 Dec; 15(12):2413-30. PubMed ID: 11127206
[TBL] [Abstract][Full Text] [Related]
4. Timing of Egf treatment differentially affects Tgf-beta2 induced cranial suture closure.
Rawlins JT; Fernandez CR; Cozby ME; Opperman LA
Exp Biol Med (Maywood); 2008 Dec; 233(12):1518-26. PubMed ID: 18849541
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.
Opperman LA; Nolen AA; Ogle RC
J Bone Miner Res; 1997 Mar; 12(3):301-10. PubMed ID: 9076572
[TBL] [Abstract][Full Text] [Related]
6. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
7. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production.
Opperman LA; Chhabra A; Nolen AA; Bao Y; Ogle RC
J Craniofac Genet Dev Biol; 1998; 18(3):150-8. PubMed ID: 9785219
[TBL] [Abstract][Full Text] [Related]
8. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion.
Roth DA; Longaker MT; McCarthy JG; Rosen DM; McMullen HF; Levine JP; Sung J; Gold LI
J Bone Miner Res; 1997 Mar; 12(3):311-21. PubMed ID: 9076573
[TBL] [Abstract][Full Text] [Related]
9. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro.
Opperman LA; Chhabra A; Cho RW; Ogle RC
J Craniofac Genet Dev Biol; 1999; 19(3):164-73. PubMed ID: 10589398
[TBL] [Abstract][Full Text] [Related]
10. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration.
Opperman LA; Galanis V; Williams AR; Adab K
Orthod Craniofac Res; 2002 Feb; 5(1):5-16. PubMed ID: 12071374
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta2 regulates growth and differentiation of pulp cells via ALK5/Smad2/3.
Tai TF; Chan CP; Lin CC; Chen LI; Jeng JH; Chang MC
J Endod; 2008 Apr; 34(4):427-32. PubMed ID: 18358889
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo.
Opperman LA; Moursi AM; Sayne JR; Wintergerst AM
Anat Rec; 2002 Jun; 267(2):120-30. PubMed ID: 11997880
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules.
Lee JY; Kim KH; Shin SY; Rhyu IC; Lee YM; Park YJ; Chung CP; Lee SJ
J Biomed Mater Res A; 2006 Mar; 76(3):530-9. PubMed ID: 16331652
[TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone stimulates proliferation and differentiation of fetal calvarial osteoblasts and dural cells and induces cranial suture fusion.
Lin IC; Slemp AE; Hwang C; Sena-Esteves M; Nah HD; Kirschner RE
Plast Reconstr Surg; 2007 Oct; 120(5):1137-1147. PubMed ID: 17898587
[TBL] [Abstract][Full Text] [Related]
18. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
19. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
20. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
